ELREXFIO
This dual binding process activates T cells to target and destroy myeloma cells with BCMA on their surface. It may also harm a type of normal antibody-producing cell.
This dual binding process activates T cells to target and destroy myeloma cells with BCMA on their surface. It may also harm a type of normal antibody-producing cell.